Non-cancerous body tissue that should be spared from radiation.Healthy tissue refers to the normal, non-cancerous cells and organs in a patient's body that must be protected during medical treatments, especially radiation therapy. The goal of many cancer treatments is to deliver a lethal dose to tumor cells while minimizing damage to surrounding healthy tissue, because radiation can cause mutations, cell death, and long-term side effects.
The concept became central to radiotherapy in the early 20th century, as physicians like Marie Curie's daughter Irène Joliot-Curie and others worked to improve dose delivery, but the systematic study of tissue tolerance dates to the 1930s–1940s.
Radiation damages DNA, and both cancer and healthy cells are affected. However, cancer cells often divide more rapidly and are less efficient at repairing damage, making them more vulnerable. Techniques like shaping radiation beams, using multiple angles, or delivering protons that stop at a precise depth exploit this difference, concentrating the dose on the tumor and sparing healthy tissue. Imaging and planning software help map the tumor's location relative to critical organs.
It is the guiding principle in modern radiation oncology, including proton therapy and intensity-modulated radiation therapy, where treatment plans are optimized to spare organs like the brain, lungs, and heart.
The tolerance of healthy tissue to radiation varies by organ—for example, the lens of the eye is highly sensitive, while the skin can withstand much higher doses.









